Jessica M Logan

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Diffusion Weighted Imaging

Tyrosine Kinase

Inflammatory Response

Dendritic Cells

Top Venues

Journal of oncology

JNCI cancer spectrum

This page only lists publications with an associated author ORCID identifier.

Publications

Mark A Miles, Raymond Luong, Eunice E To, Jonathan R Erlich, Stella Liong, Felicia Liong, Jessica M Logan, John J O'Leary, Douglas A Brooks, Stavros Selemidis
TLR9 Monotherapy in Immune-Competent Mice Suppresses Orthotopic Prostate Tumor Development. Cells 13 (1) (2024)
Mark A Miles, Raymond Luong, Eunice E To, Jonathan R Erlich, Stella Liong, Felicia Liong, Jessica M Logan, John J O'Leary, Douglas A Brooks, Stavros Selemidis
TLR9 Monotherapy in Immune-Competent Mice Suppresses Orthotopic Prostate Tumor Development. Cells 13 (1) (2024)
Mark A Miles, Raymond Luong, Eunice E To, Jonathan R Erlich, Stella Liong, Felicia Liong, Jessica M Logan, John J O'Leary, Douglas A Brooks, Stavros Selemidis
TLR9 Monotherapy in Immune-Competent Mice Suppresses Orthotopic Prostate Tumor Development. Cells 13 (1) (2024)
Mark A Miles, Raymond Luong, Eunice E To, Jonathan R Erlich, Stella Liong, Felicia Liong, Jessica M Logan, John J O'Leary, Douglas A Brooks, Stavros Selemidis
TLR9 Monotherapy in Immune-Competent Mice Suppresses Orthotopic Prostate Tumor Development. Cells 13 (1) (2024)
Giang T Lam, Carmela Martini, Tiffany Brooks, Sarita Prabhakaran, Ashley M Hopkins, Ben S-Y Ung, Jingying Tang, Maria C Caruso, Robert D Brooks, Ian R D Johnson, Alexandra Sorvina, Shane M Hickey, Litsa Karageorgos, Sonja Klebe, John J O'Leary, Douglas A Brooks, Jessica M Logan
Insights into Melanoma Clinical Practice: A Perspective for Future Research. Cancers 15 (18) (2023)
Ashley M Hopkins, Jessica M Logan, Ganessan Kichenadasse, Michael J Sorich
Artificial intelligence chatbots will revolutionize how cancer patients access information: ChatGPT represents a paradigm-shift. JNCI cancer spectrum 7 (2) (2023)
Jessica M Logan, Ashley M Hopkins, Carmela Martini, Alexandra Sorvina, Prerna Tewari, Sarita Prabhakaran, Chelsea Huzzell, Ian R D Johnson, Shane M Hickey, Ben S-Y Ung, Joanna Lazniewska, Robert D Brooks, Courtney R Moore, Maria C Caruso, Litsa Karageorgos, Cara M Martin, Sharon A O'Toole, Laura Bogue Edgerton, Mark P Ward, Mark Bates, Stavros Selemidis, Adrian Esterman, Sheena Heffernan, Helen Keegan, Sarah Ní Mhaolcatha, Roisin O'Connor, Victoria Malone, Marguerite Carter, Katie Ryan, Andres Clarke, Nathan Brady, Sonja Klebe, Hemamali Samaratunga, Brett Delahunt, Michael J Sorich, Kim Moretti, Lisa M Butler, John J O'Leary, Douglas A Brooks
Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1. Cancers 15 (12) (2023)
Jessica M Logan, Ashley M Hopkins, Carmela Martini, Alexandra Sorvina, Prerna Tewari, Sarita Prabhakaran, Chelsea Huzzell, Ian R D Johnson, Shane M Hickey, Ben S-Y Ung, Joanna Lazniewska, Robert D Brooks, Courtney R Moore, Maria C Caruso, Litsa Karageorgos, Cara M Martin, Sharon A O'Toole, Laura Bogue Edgerton, Mark P Ward, Mark Bates, Stavros Selemidis, Adrian Esterman, Sheena Heffernan, Helen Keegan, Sarah Ní Mhaolcatha, Roisin O'Connor, Victoria Malone, Marguerite Carter, Katie Ryan, Andres Clarke, Nathan Brady, Sonja Klebe, Hemamali Samaratunga, Brett Delahunt, Michael J Sorich, Kim Moretti, Lisa M Butler, John J O'Leary, Douglas A Brooks
Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1. Cancers 15 (12) (2023)
Giang T Lam, Sarita Prabhakaran, Alexandra Sorvina, Carmela Martini, Ben S-Y Ung, Litsa Karageorgos, Shane M Hickey, Joanna Lazniewska, Ian R D Johnson, Desmond B Williams, Sonja Klebe, Victoria Malone, John J O'Leary, Louise Jackett, Doug A Brooks, Jessica M Logan
Pitfalls in Cutaneous Melanoma Diagnosis and the Need for New Reliable Markers. Molecular diagnosis & therapy (2022)
Jessica M Logan, Douglas A Brooks, Andrew Rowland, Michael J Sorich, Ashley M Hopkins
Survival Outcomes of Nonsmall Cell Lung Cancer Patients Treated with Afatinib Who Are Affected by Early Adverse Events. Journal of oncology 2021 (2021)